Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myomo Inc (MYO)

Myomo Inc (MYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,810
  • Shares Outstanding, K 38,512
  • Annual Sales, $ 40,930 K
  • Annual Income, $ -15,570 K
  • EBIT $ -14 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.17
  • Price/Sales 0.75
  • Price/Cash Flow N/A
  • Price/Book 2.67
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings $-0.08 on 03/09/26
  • Next Earnings Date 05/06/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Options Overview Details

View History
  • Implied Volatility 369.30% (-5.96%)
  • Historical Volatility 78.69%
  • IV Percentile 71%
  • IV Rank 25.09%
  • IV High 1,273.78% on 09/18/25
  • IV Low 66.41% on 06/27/25
  • Expected Move (DTE 1) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 38
  • Volume Avg (30-Day) 47
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 4,065
  • Open Int (30-Day) 3,777
  • Expected Range 0.7940 to 0.7940

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.12
  • Number of Estimates 2
  • High Estimate $-0.11
  • Low Estimate $-0.12
  • Prior Year $-0.08
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6050 +31.24%
on 03/31/26
0.8217 -3.37%
on 04/16/26
+0.0542 (+7.33%)
since 03/16/26
3-Month
0.6050 +31.24%
on 03/31/26
1.0200 -22.16%
on 01/22/26
-0.1660 (-17.29%)
since 01/16/26
52-Week
0.6050 +31.24%
on 03/31/26
4.9883 -84.08%
on 05/02/25
-3.4760 (-81.41%)
since 04/16/25

Most Recent Stories

More News
Myomo Appoints William J Febbo to its Board of Directors

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 0.7940 (-0.75%)
OPRX : 6.64 (+3.75%)
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources ...

MYO : 0.7940 (-0.75%)
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.7940 (-0.75%)
Myomo to Report Fourth Quarter 2025 Financial Results on March 9

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.7940 (-0.75%)
Myomo Reports Third Quarter 2025 Financial and Operating Results

Revenue of $10.1 million 229 authorizations and orders, highest number this year Reiterates full year revenue guidance of $40 million to $42...

MYO : 0.7940 (-0.75%)
Myomo to Report Third Quarter 2025 Financial Results on November 10

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.7940 (-0.75%)
Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.7940 (-0.75%)
Myomo Reports Second Quarter 2025 Financial and Operating Results

Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance ...

MYO : 0.7940 (-0.75%)
Myomo to Report Second Quarter 2025 Financial Results on August 11

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.7940 (-0.75%)
AI and Biotech Developers Lead the Charge in the Next Healthcare Transformation

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Earlier this year, US President Joe Biden and his administration put out a new executive order on safe, secure, and...

MYO : 0.7940 (-0.75%)
AVAI : 0.3200 (+1.27%)
PRCT : 24.52 (-4.48%)
ABSI : 3.23 (+1.89%)
ISRG : 458.08 (-2.19%)

Business Summary

Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed...

See More

Key Turning Points

3rd Resistance Point 0.8588
2nd Resistance Point 0.8403
1st Resistance Point 0.8171
Last Price 0.7940
1st Support Level 0.7754
2nd Support Level 0.7569
3rd Support Level 0.7337

See More

52-Week High 4.9883
Fibonacci 61.8% 3.3139
Fibonacci 50% 2.7966
Fibonacci 38.2% 2.2794
Last Price 0.7940
52-Week Low 0.6050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.